Clinical Trial Update: Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating adding axitinib to standard chemotherapy for malignant pleural mesothelioma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• Axitinib (Axitinib)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Malignant Pleural Mesothelioma | Phase 1, Phase 2 | Status: COMPLETED